Sex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndrome

Anastasios Kallianos,1 Athanasios Panoutsopoulos,1 Christoforos Mermigkis,2 Konstantinos Kostopoulos,1 Chrysanthi Papamichail,1 Ioannis Kokkonouzis,3 Christoforos Kostopoulos,1 Ioannis Nikolopoulos,4 Antonis Papaiwannou,5 Sofia Lampaki,5 John Organtzis,5 Georgia Pitsiou,5 Paul Zarogoulidis,5 Georgia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kallianos A, Panoutsopoulos A, Mermigkis C, Kostopoulos K, Papamichail C, Kokkonouzis I, Kostopoulos C, Nikolopoulos I, Papaiwannou A, Lampaki S, Organtzis J, Pitsiou G, Zarogoulidis P, Trakada G
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2015
Materias:
CRP
Acceso en línea:https://doaj.org/article/e184202d4cd24f1ebb08db1971881804
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e184202d4cd24f1ebb08db1971881804
record_format dspace
institution DOAJ
collection DOAJ
language EN
topic Obstructive sleep apnea syndrome
CPAP
CRP
blood pressure
glucose control.
Geriatrics
RC952-954.6
spellingShingle Obstructive sleep apnea syndrome
CPAP
CRP
blood pressure
glucose control.
Geriatrics
RC952-954.6
Kallianos A
Panoutsopoulos A
Mermigkis C
Kostopoulos K
Papamichail C
Kokkonouzis I
Kostopoulos C
Nikolopoulos I
Papaiwannou A
Lampaki S
Organtzis J
Pitsiou G
Zarogoulidis P
Trakada G
Sex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndrome
description Anastasios Kallianos,1 Athanasios Panoutsopoulos,1 Christoforos Mermigkis,2 Konstantinos Kostopoulos,1 Chrysanthi Papamichail,1 Ioannis Kokkonouzis,3 Christoforos Kostopoulos,1 Ioannis Nikolopoulos,4 Antonis Papaiwannou,5 Sofia Lampaki,5 John Organtzis,5 Georgia Pitsiou,5 Paul Zarogoulidis,5 Georgia Trakada1 1Sleep Disorders Unit, Department of Clinical Therapeutics, “Alexandra” General Hospital, Athens School of Medicine, 2Sleep Disorders Unit, Pulmonary Department, 401 General Army Hospital, 3Pulmonary Department, 251 Hellenic Air Force General Hospital, 4Sleep Disorders Unit, “Sotiria” Regional Chest Diseases Hospital of Athens, Athens, Greece; 5Pulmonary Department – Oncology Unit, George Papanikolaou General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, GreeceIntroduction: There is growing research evidence suggesting the presence of endothelial dysfunction and systemic inflammation in patients with obstructive sleep apnea syndrome (OSAS). Continuous positive airway pressure (CPAP) is the most effective method for treating OSAS; nonetheless, the effects of CPAP on the aforementioned pathophysiologic pathways as well as on the systemic disease that result or coexist with the OSAS remain elusive.Aim: To assess the effect of 3-month CPAP therapy on endothelial-dependent dilation, plasma levels of inflammatory markers, blood pressure (BP), and glucose control on male and female patients with OSAS.Methods: Our study group consisted of 40 (24 males and 16 females) patients with no prior history of cardiovascular disease, with an apnea–hypopnea index ≥15, who were assigned to receive CPAP treatment. Measurements of flow-mediated dilation (FMD), 24-hour ambulatory BP, and blood analysis were performed at baseline and 3 months after CPAP therapy.Results: Baseline FMD values were negatively correlated with the apnea–hypopnea index (r=−0.55, P=0.001). After 3 months of CPAP, there was an increase in the FMD values (5.40%±2.91% vs 3.13%±3.15%, P<0.05) and a significant reduction in the patients’ 24-hour systolic BP (122.82±11.88 mmHg vs 130.24±16.75 mmHg, P<0.05), diastolic BP (75.44±9.14 mmHg vs 79.68±11.09 mmHg, P<0.05), and pulse pressure (47.38±9.77 mmHg vs 52.72±11.38 mmHg, P<0.05); daytime systolic BP (125.76±12.69 mmHg vs 132.55±17.00 mmHg, P<0.05) and diastolic BP (77.88±10.39 mmHg vs 82.25±11.01 mmHg, P<0.05); nighttime systolic BP (118.17±13.16 mmHg vs 126.22±17.42 mmHg, P<0.05) and pulse pressure (46.61±10.76 mmHg vs 52.66±11.86 mmHg, P<0.05); and C-reactive protein and HbA1c levels (0.40 [0.40–0.70] mg/L vs 0.60 [0.40–0.84] mg/L and 5.45%±0.70% vs 5.95%±1.08%, respectively; P<0.05). When divided by sex, only male patients produced similar statistically significant results, while female patients failed to show such associations.Conclusion: Our results suggest that CPAP therapy improves the endothelial function, the BP, and the glucose control in male patients with OSAS. Further research is warranted in order to verify these results and to further elucidate the impact of CPAP on the cardiovascular risk of male and female patients with OSAS. Keywords: obstructive sleep apnea syndrome, CPAP, CRP, blood pressure, glucose control
format article
author Kallianos A
Panoutsopoulos A
Mermigkis C
Kostopoulos K
Papamichail C
Kokkonouzis I
Kostopoulos C
Nikolopoulos I
Papaiwannou A
Lampaki S
Organtzis J
Pitsiou G
Zarogoulidis P
Trakada G
author_facet Kallianos A
Panoutsopoulos A
Mermigkis C
Kostopoulos K
Papamichail C
Kokkonouzis I
Kostopoulos C
Nikolopoulos I
Papaiwannou A
Lampaki S
Organtzis J
Pitsiou G
Zarogoulidis P
Trakada G
author_sort Kallianos A
title Sex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndrome
title_short Sex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndrome
title_full Sex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndrome
title_fullStr Sex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndrome
title_full_unstemmed Sex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndrome
title_sort sex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndrome
publisher Dove Medical Press
publishDate 2015
url https://doaj.org/article/e184202d4cd24f1ebb08db1971881804
work_keys_str_mv AT kallianosa sexdifferencesofcontinuouspositiveairwaypressuretreatmentonflowmediateddilationinnbsppatientswithobstructivesleepapneasyndrome
AT panoutsopoulosa sexdifferencesofcontinuouspositiveairwaypressuretreatmentonflowmediateddilationinnbsppatientswithobstructivesleepapneasyndrome
AT mermigkisc sexdifferencesofcontinuouspositiveairwaypressuretreatmentonflowmediateddilationinnbsppatientswithobstructivesleepapneasyndrome
AT kostopoulosk sexdifferencesofcontinuouspositiveairwaypressuretreatmentonflowmediateddilationinnbsppatientswithobstructivesleepapneasyndrome
AT papamichailc sexdifferencesofcontinuouspositiveairwaypressuretreatmentonflowmediateddilationinnbsppatientswithobstructivesleepapneasyndrome
AT kokkonouzisi sexdifferencesofcontinuouspositiveairwaypressuretreatmentonflowmediateddilationinnbsppatientswithobstructivesleepapneasyndrome
AT kostopoulosc sexdifferencesofcontinuouspositiveairwaypressuretreatmentonflowmediateddilationinnbsppatientswithobstructivesleepapneasyndrome
AT nikolopoulosi sexdifferencesofcontinuouspositiveairwaypressuretreatmentonflowmediateddilationinnbsppatientswithobstructivesleepapneasyndrome
AT papaiwannoua sexdifferencesofcontinuouspositiveairwaypressuretreatmentonflowmediateddilationinnbsppatientswithobstructivesleepapneasyndrome
AT lampakis sexdifferencesofcontinuouspositiveairwaypressuretreatmentonflowmediateddilationinnbsppatientswithobstructivesleepapneasyndrome
AT organtzisj sexdifferencesofcontinuouspositiveairwaypressuretreatmentonflowmediateddilationinnbsppatientswithobstructivesleepapneasyndrome
AT pitsioug sexdifferencesofcontinuouspositiveairwaypressuretreatmentonflowmediateddilationinnbsppatientswithobstructivesleepapneasyndrome
AT zarogoulidisp sexdifferencesofcontinuouspositiveairwaypressuretreatmentonflowmediateddilationinnbsppatientswithobstructivesleepapneasyndrome
AT trakadag sexdifferencesofcontinuouspositiveairwaypressuretreatmentonflowmediateddilationinnbsppatientswithobstructivesleepapneasyndrome
_version_ 1718403837050486784
spelling oai:doaj.org-article:e184202d4cd24f1ebb08db19718818042021-12-02T00:20:57ZSex differences of continuous positive airway pressure treatment on flow-mediated dilation in patients with obstructive sleep apnea syndrome1178-1998https://doaj.org/article/e184202d4cd24f1ebb08db19718818042015-08-01T00:00:00Zhttps://www.dovepress.com/sex-differences-of-continuous-positive-airway-pressure-treatment-on-fl-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Anastasios Kallianos,1 Athanasios Panoutsopoulos,1 Christoforos Mermigkis,2 Konstantinos Kostopoulos,1 Chrysanthi Papamichail,1 Ioannis Kokkonouzis,3 Christoforos Kostopoulos,1 Ioannis Nikolopoulos,4 Antonis Papaiwannou,5 Sofia Lampaki,5 John Organtzis,5 Georgia Pitsiou,5 Paul Zarogoulidis,5 Georgia Trakada1 1Sleep Disorders Unit, Department of Clinical Therapeutics, “Alexandra” General Hospital, Athens School of Medicine, 2Sleep Disorders Unit, Pulmonary Department, 401 General Army Hospital, 3Pulmonary Department, 251 Hellenic Air Force General Hospital, 4Sleep Disorders Unit, “Sotiria” Regional Chest Diseases Hospital of Athens, Athens, Greece; 5Pulmonary Department – Oncology Unit, George Papanikolaou General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, GreeceIntroduction: There is growing research evidence suggesting the presence of endothelial dysfunction and systemic inflammation in patients with obstructive sleep apnea syndrome (OSAS). Continuous positive airway pressure (CPAP) is the most effective method for treating OSAS; nonetheless, the effects of CPAP on the aforementioned pathophysiologic pathways as well as on the systemic disease that result or coexist with the OSAS remain elusive.Aim: To assess the effect of 3-month CPAP therapy on endothelial-dependent dilation, plasma levels of inflammatory markers, blood pressure (BP), and glucose control on male and female patients with OSAS.Methods: Our study group consisted of 40 (24 males and 16 females) patients with no prior history of cardiovascular disease, with an apnea–hypopnea index ≥15, who were assigned to receive CPAP treatment. Measurements of flow-mediated dilation (FMD), 24-hour ambulatory BP, and blood analysis were performed at baseline and 3 months after CPAP therapy.Results: Baseline FMD values were negatively correlated with the apnea–hypopnea index (r=−0.55, P=0.001). After 3 months of CPAP, there was an increase in the FMD values (5.40%±2.91% vs 3.13%±3.15%, P<0.05) and a significant reduction in the patients’ 24-hour systolic BP (122.82±11.88 mmHg vs 130.24±16.75 mmHg, P<0.05), diastolic BP (75.44±9.14 mmHg vs 79.68±11.09 mmHg, P<0.05), and pulse pressure (47.38±9.77 mmHg vs 52.72±11.38 mmHg, P<0.05); daytime systolic BP (125.76±12.69 mmHg vs 132.55±17.00 mmHg, P<0.05) and diastolic BP (77.88±10.39 mmHg vs 82.25±11.01 mmHg, P<0.05); nighttime systolic BP (118.17±13.16 mmHg vs 126.22±17.42 mmHg, P<0.05) and pulse pressure (46.61±10.76 mmHg vs 52.66±11.86 mmHg, P<0.05); and C-reactive protein and HbA1c levels (0.40 [0.40–0.70] mg/L vs 0.60 [0.40–0.84] mg/L and 5.45%±0.70% vs 5.95%±1.08%, respectively; P<0.05). When divided by sex, only male patients produced similar statistically significant results, while female patients failed to show such associations.Conclusion: Our results suggest that CPAP therapy improves the endothelial function, the BP, and the glucose control in male patients with OSAS. Further research is warranted in order to verify these results and to further elucidate the impact of CPAP on the cardiovascular risk of male and female patients with OSAS. Keywords: obstructive sleep apnea syndrome, CPAP, CRP, blood pressure, glucose controlKallianos APanoutsopoulos AMermigkis CKostopoulos KPapamichail CKokkonouzis IKostopoulos CNikolopoulos IPapaiwannou ALampaki SOrgantzis JPitsiou GZarogoulidis PTrakada GDove Medical PressarticleObstructive sleep apnea syndromeCPAPCRPblood pressureglucose control.GeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 10, Pp 1361-1367 (2015)